Directors, deputy general managers...The wave of resignations of senior executives of listed pharmaceutical companies continues!

Recently, the wave of resignations in the pharmaceutical industry has continued.
Many listed company directors, deputy general managers, employee representative supervisors and other executives have announced their resignations, including Fudan Zhangjiang, Stellite, and Jianfan Bio.
.
.
Look, it is generally due to personal reasons
.
Fudan Zhangjiang: Chairman of the Board of Supervisors resigns On October 12, 2021, Zhangjiang of Fudan issued an announcement stating that the Board of Supervisors of the company received a resignation report from the Chairman of the Board of Supervisors, Mr.
Tang Yukuan, on October 11, 2021.
Mr.
Tang Yukuan applied to the Board of Supervisors for his resignation due to personal adjustments.
The chairman of the company's seventh board of supervisors and shareholder representative supervisors will no longer hold any positions in the company after resignation
.
Kangyuan Pharmaceutical: Director resigns On October 11, Kangyuan Pharmaceutical announced that the company’s board of directors recently received a resignation report from Director, Deputy General Manager, Board Secretary and Chief Financial Officer Yin Honggang.
Yin Honggang applied to resign all of the above positions due to personal reasons.
After resignation, he will not hold any position in the company
.
The announcement shows that Yin Honggang's resignation will not affect the normal operation of the company's daily operations, and the resignation report will take effect on the day it is delivered to the board of directors
.
At the same time, before the company has formally appointed a new board secretary, Xiao Wei, the company's chairman, temporarily assumes the duties of the board secretary
.
Stellite: Director resigns On October 12, Stellite announced that the company’s board of directors recently received a written resignation report from the company’s director and deputy general manager, Mr.
Li Huajun.
Mr.
Li Huajun applied to resign all the above positions due to personal reasons.
After that, he will not hold any position in the company
.
As of the disclosure date of this announcement, Mr.
Li Huajun has been granted 29,200 restricted shares in the company's 2020 restricted stock incentive plan
.
The restricted stocks he holds after his resignation will be implemented in accordance with the relevant regulations of the equity incentive system
.
Sansheng Guojian Pharmaceutical: Resignation of Employee Supervisors On October 11, Sansheng Guojian Pharmaceutical issued an announcement stating that on September 30, 2021, the company’s board of supervisors received a written resignation report submitted by Ms.
Jiang Lili, the employee representative supervisor of the fourth board of supervisors.

.
Ms.
Jiang Lili applied to resign from the position of employee representative supervisor of the 4th Board of Supervisors of the company due to personal reasons
.
At the same time, in order to improve the corporate governance structure and ensure the standardized operation of the company's board of supervisors, the company held a staff representative meeting on September 30, 2021, and elected Ms.
Wu Jing as the employee representative supervisor of the company's fourth board of supervisors
.
Yuandong Bio: Personnel changes of several senior executives On October 12, Yuandong Bio issued an announcement that several senior executives of the company had personnel changes
.
Among them, Wang Wuping resigned from the post of secretary of the board of directors due to personal reasons, and his resignation time is October 11, 2021
.
It is understood that Wang Wuping has assumed this position in the company from December 21, 2015
.
In addition, Wang Yiou assumed the position of Secretary of the Board of Directors, taking office on October 11, 2021
.
Jianfan Biological: The Secretary of the Board of Directors resigns On September 30, Jianfan Biological issued an announcement regarding the resignation of the Secretary of the Board of Directors of the company
.
The announcement stated that the board of directors received a written resignation report from the company’s board secretary, Mr.
Zhang Mingyuan, on September 30, 2021.
Mr.
Zhang Mingyuan applied for resignation from the company’s board of directors due to personal reasons, and would no longer hold any position in the company after resignation
.
It is reported that the original term of office of Mr.
Zhang Mingyuan as secretary of the company's board of directors is until April 27, 2023
.
As of the disclosure date of this announcement, Mr.
Zhang Mingyuan holds 119,525 shares of the company, accounting for 0.
01% of the company's current total share capital
.
The announcement shows that the company's chairman and general manager, Mr.
Dong Fan, will temporarily perform the duties of the board secretary during the period when the company has not formally appointed a new secretary to the board of directors
.